State of the Science: Managing C Difficile Infections
There are several emerging treatments for C difficile infections.
Read More
Addressing Challenges in Depression Treatment
There is a need for new medications for depression to overcome high rates of treatment resistance.
Institutional Perspectives in Rheumatology: ANCA-associated Vasculitis
Dr. Kenneth J. Warrington led the panel in discussing various topics in rheumatology.
Institutional Perspectives in Psychiatry: Addressing Challenges in Depression Treatment
Subhdeep Virk, MBBS, chaired the recent State of the Science event on treatment-resistant depression.
Emerging Insulin Therapies for the Management of Type 2 Diabetes
Dr. Serge Jabbour led the panel in discussing emerging treatments for type 2 diabetes.
VaxEffect Test Measures and Tracks Immune Response to COVID-19 Vaccines
FlowMetric, Inc., discusses its VaxEffect, an immune monitoring platform and how it can be used to measure COVID-19 vaccine responses.
CDC Releases Allergy Guidelines for COVID-19 Vaccine
Those with a history of severe allergic reaction to vaccines are recommended to consider deferring on the recently approved COVID-19 vaccine.
Vision Problems More Common in Patients with Parkinson Disease
Study data suggested that up to 80% of patients with Parkinson disease may have ophthalmologic symptoms.
FDA Approves First Quadrivalent, Adjuvanted Flu Vaccine for Older Adults
The FDA has approved a quadrivalent formula of the adjuvanted seasonal influenza vaccine from Seqiris.